Skip to main content
Caplight Logo









Digma Medical

Digma Medical

Private
IsraelHealthcare & Life Scienceshttps://digmamedical.com/

Last Round

VC Round

Sep 19, 2024

Total Funding Raised

$2.76M

Company Overview

Digma Medical is a medical technology company that develops minimally invasive endoscopic therapies for the treatment of metabolic diseases and gastroenterology pathologies.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS

AI Layer

Non-AI

Keywords

medical deviceendoscopic therapymetabolic diseaseablation therapyinterventional endoscopymedtechendoscopic glycemic managementEGMendoscopic gastrointestinal ablation deviceEGADBarrett's esophagusrazor-and-blade modelminimally invasive surgerytype 2 diabetes treatmentgastroenterology equipment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Digma Medical Comparables

Compare Digma Medical with similar companies based on industry and business-model similarity.

Digma Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Endogenex
86%
Aqua Medical
86%
Fractyl Health
85%

Digma Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundSep 19, 2024
AcceleratorJun 7, 2022
VC RoundMay 19, 2022
VC RoundMay 1, 2018
Series BDec 1, 2016
Series A
Apr 1, 2015

Digma Medical Investors

Notable investors and investment history

Digma Medical investors
InvestorRounds
MedTech InnovatorAccelerator
Bread & Butter VenturesVC Round
Capita3VC Round
Peregrine VenturesSeed, VC Round, Series B
AccelmedVC Round, Series B, Series A
Arkin CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 11, 2025

    Monthly visitors grew 378% MoM, from 540 to 2.6K.

  • Sep 19, 2024

    $27M raised with Bread & Butter Ventures and Capita3.

Digma Medical Filings

Explore SEC and related filing metadata, where available.

Digma Medical filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Digma Medical's valuation, stock price, and market status.

Is Digma Medical a public or private company?

Digma Medical is a private company.

What is the current stock price of Digma Medical?

Digma Medical is a private company with no public stock price. No recent secondary market data is available.

How much is Digma Medical worth (valuation)?

Valuation information for Digma Medical is not publicly available.

Can I buy Digma Medical stock?

Digma Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Digma Medical's last funding round?

Funding round information for Digma Medical is not publicly available.

Who are the main investors in Digma Medical?

Investor information for Digma Medical is not publicly disclosed.

Will Digma Medical IPO soon?

No public IPO plans have been announced for Digma Medical.

How can I track Digma Medical secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Digma Medical's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersIsrael
Employee Range6
Year Founded2013
Last FundingSep 19, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?